Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Calendar days.
I don't believe that March 7th marked the end of the phase1 assessment process
It seems logical that the 150-day assessment period began on January 24, 2024, when the initial validation was confirmed. The March 7, 2024, confirmation likely served as an additional administrative check within the ongoing Phase 1 review process to ensure all documentation was in place and that the application was qualified for the 150-day assessment route.
StonkMaster,
I believe the 150-day assessment begane on Jan.24
IMO, it doesn't make sense to suggest that the 150-day assessment would begin on March 7, given that the standard process typically takes 210 days. Starting the rapid assessment 43 days after the validation confirmation would unnecessarily delay the process. It is logical to conclude that the 150-day assessment began on January 24, when the MAA initially passed validation.
CHATgpt:
May 9, 2024
Les Goldman says "they are on track for accelerated approval (150- day assessment)" witch is new information.
We know that Northwest Biotherapeutics has requested the MHRA to allow the 150-day assessment route.
December 21, 2023
Children and teenagers could benefit after a new targeted combination treatment for a rare, aggressive form of brain cancer was recommended today.
— NICE (@NICEComms) April 24, 2024
Find out more about how dabrafenib with trametinib works: https://t.co/LCkav3pgIP#NICENews pic.twitter.com/BKvjuKcVdo
TODAY MAY 22
7-8 a.m.
Join via ZOOM
Meeting ID: 913 1277 5742
Tomorrow we are honored to host @EKNduom from @EmoryNeurosurg for #Neurosurgery #GrandRounds. Esteemed surgeon, scientist, #Advocate, and leader @CNS_Update, we are excited for his talk "New Approaches to Immune Therapy for #Glioblastoma: Lessons Learned". @GWSMHS #CancerMoonshot pic.twitter.com/pnFlB1j2fI
— George Washington Neurosurgery (@GWnsgy) May 21, 2024
At the tumor session with Dr. Liau and Dr. Lim! #AANS2024 @MichaelLimMD @UCLANsgy @IsaacYangMD @AANSNeuro @StanfordNsurg #WhatMatters2Me pic.twitter.com/h5mFIOSmGc
— The Yang Lab (@TheYangLab1) May 5, 2024
AANS2024 Chicago
Monday, May 6, 2024
11:06 AM – 11:26 AM CT
Location: S503ab
Linda Liau – Immunotherapy.
Congratulations to the stellar lineup of UCLA #Neurosurgery Faculty & Residents who are scheduled at the @AANSNeuro Annual Meeting this weekend! Schedule: https://t.co/y6CRiQe2fi@ausaf @geoffreycolbymd @SpineNeuro @inspired_brain @IsaacYangMD @ShivaniBaisi_MD @brainbro #AANS2024 pic.twitter.com/oQ8oHKHmyz
— UCLA Neurosurgery 🧠 (@UCLANsgy) May 1, 2024
FORM 10-K/A (Amendment No. 1) filed April 29: https://www.otcmarkets.com/filing/html?id=17489512&guid=d5Q-kqGyIgi7B3h
Last Friday, we were honored to have Dr. Linda Liau as our 42nd Annual J. Jay Keegan Lecturer. It was an extraordinary afternoon for our residents with a phenomenal presentation and dinner to follow. We are so indebted to Dr. Liau for her time here in #Omaha. @unmc @UCLANsgy pic.twitter.com/tqb36hpn6w
— UNMC Department of Neurosurgery (@UNMC_NeuroSurg) April 22, 2024
Calendar days and not business (working) days.
From MHRA:
Guidance
International Recognition Procedure - supplementary information
Updated 8 April 2024
Ex,
EAMS medicines are provided free of charge to the NHS (National Health Service),‘Specials’ may be provided free of charge or charged (generating revenue).
From inspire.com:
I hope Dr.Mulholland’s next immunotherapy trial for people with glioblastoma (this summer?) is a combo trial with DCVax-L.
Thank you @Siobhain_Mc for campaigning on this issue. It would be amazing to get Dr Mulholland’s #immunotherapy trial for people with #glioblastoma up and running this summer. We’re with you! https://t.co/YWoEuSQ1q9
— The National Brain Appeal (@BrainAppeal) April 3, 2024
Diagnosed with a glioblastoma, Matthew is raising funds to pay for DC Vax-L treatment, which has the potential to extend his life, but is not available on the NHS. Access to new and better treatments - #ItsANoBrainer. Sign our open letter today: https://t.co/yvQSBzL5ta pic.twitter.com/oT4Dz7YB1v
— The Brain Tumour Charity (@BrainTumourOrg) March 25, 2024
Interesting Gofundme story.
Bo’s Brain Cancer Treatment.
2 days ago.
Smokey, I wish you a full recovery! Stay strong and never give up!
Thanks for sharing the podcast ( Joe Miller discusses the “bombshell lawsuit,” spoofing, and high frequency trading practices)+transcript, hyperopia!
And thanks for the Bristol Meyers/Medarex story.
New peer-reviewed publication already accepted:
The case study may be about Owain James. The tumor is 14cm, only half of it can be removed, and three vaccines were made. But with the intense anti-tumor response, the remaining half shrank into cyst under continual pounding of the immune system. I suspect that in his case the… pic.twitter.com/gAajsAtAHF
— d_stock (@d_stock07734) March 5, 2024
Updates on Neoadjuvant Checkpoint Blockade Immunotherapy for Glioblastoma.
9th Annual Advances in Brain Tumor Management Course
Feb.9, 2024
Robert M.Prins, PhD
Min.1
Min.16.15s
Conquering Glioblastoma: A Tribute to Margaret McDonagh | Official Director's Cut (2024 Movie)
Remarks around min.16m.15s
Try this. I could read it for free.(+ comments)
‘Spoofing’ case might draw back curtain on high-speed trading firms like Citadel Securities - column by @JoeMillerJr https://t.co/0rwufVPmco
— Tony Tassell (@TonyTassell) March 2, 2024
Thanks sharpie510!
Prof. Keyoumars Ashkan:
"So honoured to have been part of this event. We cannot do enough to highlight the needs of our patients. Thank you The Brain Tumour Charity for advocating for our patients."
🧠✨ Today we stand with 34 community members to honour those diagnosed with brain tumours daily.
— The Brain Tumour Charity (@BrainTumourOrg) February 29, 2024
No more waiting for change. Improving brain tumour care is a No Brainer.
Sign our open letter 👉 https://t.co/mZR1JHoSg3#ItsANoBrainer #BrainTumourAwarenessMonth pic.twitter.com/psxcp6EGJ5
#dcvax $nwbo #gbm
— Peter Davis (@peter_brit) February 29, 2024
"Debate in the Commons on a motion to introduce the Brain Tumours Bill under the ten minute rule, with Labour MP Dame Siobhain McDonagh, from Wednesday 28 February"
"Dr Paul Mulholland - he believes we are on the cusp of a cure"https://t.co/cmEg97hgKC pic.twitter.com/FiP78ILH88
#dcvax $nwbo #gbm
— Peter Davis (@peter_brit) February 29, 2024
Full text of Brain Tumours bill
Volume 746: debated on Wednesday 28 February 2024
Dame Siobhain McDonagh
(Mitcham and Morden) (Lab)
Sharethis specific contribution
I beg to move,
That leave be given to bring in a Bill to set a target for the number of… pic.twitter.com/kIPYnav5I6
📜Today I passed my 10 Minute Rule Bill for the 3,200 people who are diagnosed with a glioblastoma brain tumour every single year...
— Siobhain McDonagh (@Siobhain_Mc) February 28, 2024
Thank you to @wesstreeting and @willquince for your cross party support pic.twitter.com/x4kepaGAD2
In a groundbreaking phase III clinical trial, DCVax-L, an innovative treatment, has exhibited the potential to significantly prolong the lives of individuals grappling with both new and recurrent glioblastoma.
— EndBrainCancer Initiative (@EndBrainCancer) February 22, 2024
Learn more at https://t.co/TUXwUta6wh#GBM #clinicaltrial pic.twitter.com/Nh37518NlR
Talk about implementing digital technologies in ATMPs Manufacturing.
Autolomous presentation around min 22.30:
https://iuk.ktn-uk.org/events/sme-showcase-digital-technologies-in-medicines-manufacturing/
Icon sign & design limited.
Feb.8,
#dcvax $nwbo #gbm
— Peter Davis (@peter_brit) February 12, 2024
Found this excellent video presentation by Linda Liau
from 2021 I personally have not seen before, organized by the Pakistan Society of Neuro-Oncology. Linda starts presenting at 47 mins with her slide deck starting at 49 mins. Linda presents on session 10.… pic.twitter.com/xytQnK3CX1